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 Abstract  
 
Objective 
The goal is to present how shared decision-making in pediatric oncology occurs from the viewpoints 
of parents and physicians.  
Methods 
Eight Swiss Pediatric Oncology Group centers participated in this prospective study. The sample 
comprised a parent and physician of the minor patient (<18 years). Surveys were statistically 
analysed by comparing physicians’ and parents’ perspectives, and by evaluating factors associated 
with children’s actual involvement. 
Results 
Perspectives of 91 parents and 20 physicians were obtained for 151 children. Results indicate that for 
six aspects of information provision examined, parents’ and physicians’ perceptions differed. 
Moreover, parents felt that the children were more competent to understand diagnosis and prognosis, 
assessed the disease of the children as worse, and reported higher satisfaction with decision-making 
on the part of the children. A patient’s age and gender predicted involvement. Older children and 
girls were more likely to be involved. In the decision-making process, parents held a less active role 
than they actually wanted. 
Conclusion 
Physicians should take measures to ensure that provided information is understood correctly. 
Furthermore, they should work towards creating awareness for systematic differences between 
parents and physicians with respect to the perception of the child, the disease, and shared decision-
making. 
 





Decision-making in Pediatric Oncology 
When children are diagnosed with cancer, families and physicians face the cumbersome task of 
making urgent and difficult treatment decisions. In the pediatric setting, decision-making process 
includes multiple steps and at least three parties: the physician/nurse, the patient, and the parents: 
each with their own opinions, needs, and expectations (Whitney 2008). They form a triadic 
constellation that must share the process and make a decision in the best interest of the child. 
Literature on shared decision-making emphasizes the following aspects: a) the involvement of at 
least two parties; b) sharing of information between the parties; c) consensus regarding the preferred 
treatment; and d) successfully achieving an agreement (Charles, Gafni, and Whelan 1997; Moumjid 
et al. 2007). Shared decision-making requires the involvement of all parties with the child 
participating in a developmentally appropriate way (Craig et al. 2007). However, neither the 
participation of the child nor the ability to carry out preferred role is guaranteed. For instance, Mack 
concluded that more than one third of the parents held a passive role and that they were unsatisfied 
with the information they received (Mack et al. 2011; Mack et al. 2006). Moreover, physicians often 
face several obstacles to communication such as time limitations and uncertainty about the patient’s 
current or projected condition (Carnevale et al. 2012; Kilkelly and Donelly 2006). Finally, despite 
recommendations by international guidelines to involve children (American Academy of Pediatrics 
2013; United Nations 1989) several studies have noted that children’s participation is still low, and 
that they are often shielded from (difficult or bad) information (Pousset et al. 2010; Ruhe et al. 2014; 
Zhukovsky et al. 2009; Zwaanswijk et al. 2011). 
Factors Hindering Decision-making Process 
Forming a shared decision is not an easy process since all parties must overcome several difficulties. 
First, factors that inhibit parents include the coping with the possible loss of their child and its 
consequences for the family (Kars et al. 2015). Parents must overcome intra-familial conflicts, they 
may have unrealistic expectations regarding cure, and may deny that the cancer is terminal (Hilden et 
al. 2001). Parents’ limited understanding of the medical information, and low family educational 
level also impair their ability to adequately take part in the decision-making (White et al. 2007).  
Second, physicians perceive a series of ethical challenges in making treatment decisions. These 
include weighing what the consequences of their actions would be, questioning the role of parents, 
and uncertainty as to how the child’s wishes should be considered (Carnevale et al. 2012). 
Physician’s wishes to maintain some degree of hope may result in avoiding frank disclosure, thereby 
hindering decision-making. Furthermore, they face difficulties when asked “to provide uniquely 
 tailored, culturally appropriate, holistic, comprehensive, coordinated, long-term care to all families” 
(Jones, Contro, and Koch 2014, 13; Mack and Joffe 2014; Mack et al. 2006). These concerns become 
more burdensome in light of little formalized training that physicians receive in pediatric palliative 
care, and in light of their reliance on learning through trial and error (Hilden et al. 2001; Jones, 
Contro, and Koch 2014; Zhukovsky et al. 2009). 
Study Purpose 
Available literature illustrates the need to shift the actual decision-making towards a process that 
empowers every involved person to occupy the preferred role. To know more about how shared 
decision-making in these situations occurs and how children are involved, more studies are needed. 
This research gap was addressed in this study carried out with physicians working in Swiss Pediatric 
Oncology Group (SPOG) centers and parents of children suffering from cancer. Study participants 
were questioned about their attitudes towards child’s participation in the decision-making processes, 
their satisfaction with the process, and the actual involvement of the child. The study posed the 
following research questions: What are parents’ and physicians’ attitudes and orientation regarding 
inclusion of children in their cancer treatment decisions? What are their opinions on several aspects 





Eight of the nine SPOG-centers in Switzerland participated in this multicentre mixed methods 
project. The qualitative part of the project included interviews with children, their parents and 
physicians. The results from the qualitative interviews have been reported elsewhere (Ruhe et al. 
2015b; Ruhe et al. 2016; Wangmo et al. 2016a; Wangmo et al. 2016b). In addition, a quantitative 
collection of information using closed-ended surveys took place at the participating SPOG-centers. 
In this quantitative part, children were not included. In this paper, we report the results of the 
quantitative surveys completed by parents and physicians. Distribution of the surveys began in 
November 2012 and was carried out until April 2015. Ethical approval was obtained from the 
responsible ethics committees for each SPOG-center. This inevitably meant that data could not be 
collected at all centers at the same time. The surveys were completed on a rolling basis of when we 
received the ethics approval. The first center began distributing the surveys and collecting them in 
November 2012 and the last one in June 2013. All centers ceased data collection in April 2015. 
Study population 
 Parents and treating physicians were included in the quantitative part of the project, if the respective 
child (a) was less than 18 years of age and (b) had a cancer diagnosis and received cancer treatment 
in one of the participating SPOG-centers. The views of the pediatric patients were not gathered 
because we could not assure that young children (less than 12 years) understand and complete the 
study survey correctly. However, some variables captured children’s views indirectly through the 
parents or the physicians evaluation of the child’s view (e.g. “How satisfied was your child with 
decision-making?”, “Please evaluate your child’s suffering due to the disease”). 
Data Collection 
Before starting data collection, the research team visited the respective SPOG-centers to introduce 
the study, its methodology, and study tool to the physicians, as well as to the data manager (where 
possible). The purpose of this visit was to explain the recruitment process so that data collection 
would be as uniform as possible within each center and between different centers. Study materials 
with codes for physician and parent were labelled for each patient by the researchers and delivered to 
the participating centers. The data manager or the responsible contact person for the center kept a 
note on which participant received which code. To ensure confidentiality, the researchers did not 
have access to participants’ identifiable information. 
The study team requested each physician at the participating center to complete one survey for every 
patient he or she treated. This meant that the physicians completed multiple surveys; however, each 
was for a unique patient case. They were also asked to approach the parents for each patient for 
whom they filled out a survey. The treating physician thus informed the parents about the study and 
provided the parents the study information documents: informed consent, a survey, and refusal card. 
Based on their preference, the parents could either return the survey to the hospital in a sealed 
envelope or post it using the self-addressed stamped envelope provided. Since parents completed the 
survey within a short time span of a few weeks after they were approached by their child’s treating 
physician, we expect that within one dyad perspective, the point along the child’s disease trajectory 
(e.g. diagnosis, relapse) would not have differed greatly. By emphasizing that parents have the 
opportunity to refuse to participate and by handing over a refusal card, the study team ensured that 
no undue pressure was placed on parents, given their difficult situation. 
Study Sample 
A total of 229 surveys were completed and returned (138 by 20 treating physicians; 91 by 91 
parents) during the data collection period. These 229 responses represented 151 unique children 
cases. From the 151 children, dyad-perspective (of parent and physician) was captured for 78 
children. For 73 children only one perspective was available: 60 from the treating physician and 13 
children from a parent. We cannot confidently estimate the number of patients who sought treatment 
 at the participating SPOG-centers during the study period as this data is not obtainable for the 
research team. However, 20 of the 28 physicians at the participating SPOG participated in the study. 
Since 138 surveys were completed by the 20 physicians, we expect that 138 parents received a 
survey. From those parents who have received a survey, a completed survey was sent to the research 
team in 66 per cent of the cases. We received a total of 11 refusals from the parents. 
Study Questionnaire 
The study tool focused on the inclusion of children in the overall treatment decision-making. Several 
aspects and items of the detailed questionnaire were developed from the research team’s knowledge 
in the field and input from collaborating physicians. The survey was designed to gather the following 
data: a) demographics information; b) the amount of information given to the parents and whether 
the patient was present at this time; c) the capacity of the patient to understand disease-related 
information; d) decision-making and satisfaction with decision-making within the triadic system of 
child, parent, and physician; and e) current and preferred role of parents within decision-making. 
Questions concerning role in decision-making was adapted and revised from Mack and colleagues. 
The questionnaire consisted in items with categorical responses or Likert scales. It was pilot tested in 
August 2012 in one SPOG-center. A few adaptations were made that did not change the 
questionnaire’s overall purpose. 
Statistical Analyses 
A research assistant entered all completed surveys into SPSS.22 and another checked for correctness 
of data entry. Statistical analyses were performed using SPSS 22 (SPSS Inc, Chicago, IL). For 
analyses described below, reported P values are 2-sided and statistical significance level was set at P 
< .05. 
To understand the general age at which children are considered capable of understanding different 
treatments and related consequences, physician’s evaluation of the age from which the majority of 
children were considered able to understand various information related to their illness and capable 
of making related decisions was assessed descriptively. To be able to determine this age, we first 
counted how many children at a given age were considered capable versus how many children of the 
same age were not. Second, we examined the age at which these frequencies shifted from “more 
children were deemed not capable” to “more children were deemed capable”. This shift represented 
the “turning point” that we describe in this paper. 
Moreover, we compared physicians’ and parents’ perspectives on the decision-making process, on 
children’s characteristics, and on disease-related features. Using the 78 dyad-perspective, a Wilcoxon 
signed-rank test was carried out to evaluate differences between physicians’ and parents’ responses 
to the following seven variables: suffering of the child, prognosis of child’s cancer, capacity of the 
 patient to understand disease-related information, past and expected treatment duration, satisfactions 
with decision-making, current and preferred role of parents in decision-making, and amount of 
information given to the parents. Additionally, using the parental perspective, we compared parents’ 
current and preferred role in decision-making in order to evaluate whether they hold the role they 
wanted. 
Finally, we evaluated factors associated with the actual involvement of the child in the shared 
decision-making using Generalized Linear Mixed Model (GLMM). Categorical responses regarding 
the involved parties in decision-making (question: “who was involved in decision-making?”) were 
dichotomized into “with child” and “without child”. This binary variable was the dependent variable. 
Based on a priori theoretical considerations, four predictor variables were included: age of the child, 
gender of the child, cancer prognosis, and physician’s professional experience as a pediatric 
oncologist. Since children receiving care from a particular physician and/or center might have similar 
data, the analysis was adjusted for clustering within physicians and SPOG-centers. The GLMM 
analysis included the 138 cases that were completed by 20 physicians. 
 
Results 
Demographic Characteristics of the Sample 
62 per cent (93 of 151) of the children were male. Parents were between 18 to 59 years old and most 
of them were mothers (80 per cent, 71 of 89; two missing values). Physicians were between 35 to 58 
years old with a small majority (56 per cent) being female (10 of 18; two missing values). Other 
demographic information of patients, parents, and physicians are presented in Table 1. 
According to the 12 categories (I-XII) of International Classification of Childhood Cancer (ICCC), 
the most frequent diagnoses were as follows: leukemia (ICCC-I; 49.7 per cent), central nervous 
system neoplasms (ICCC-III; 18.5 per cent), malignant bone tumours (ICCC-VIII, 7.9 per cent), and 
lymphomas and reticuloendothelial neoplasms (ICCC-II, 6.6 per cent). Two diagnoses were not 
represented in our sample: retinoblastoma (ICCC-V) and hepatic tumours (ICCC-VII). Compared to 
Swiss Childhood Cancer Registry (SCCR), leukemia was overrepresented (49.7 per cent vs 33 per 
cent) and central nervous system neoplasms were comparable (18.5 per cent vs 19.6 per cent) (Swiss 
Childhood Cancer Registry 2016). Patients’ age were overall comparable to SCCR (in bracket): 0-4 
years 34.8 per cent (36 per cent), 5-9 years 26.2 per cent (21.5 per cent), 10-14 years 27.5 per cent 
(22.7 per cent), and 15-20 years 11.4 per cent (19.8 per cent; note: SCCR includes adolescents up to 
20 years of age). 
Physicians’ Evaluations of Children’s Understanding and Capacity 
 With regards to understanding diagnosis, only one out of four children who were 5 years of age was 
deemed capable, three out of eight children who were 6 years of age were considered capable, and 
the same goes for seven out of thirteen children who were 7 years old, and seven out of nine for 
children 8 years old. Accordingly, the turning point was reached between 6 and 7 years of age (Table 
2). Therefore, physicians judged understanding of response to treatment and understanding diagnosis 
to be easiest and thus deemed the majority of children older than 6 years to be capable of these two 
tasks. Understanding of cancer cause and prognosis was reported more positively for those children 
who were 9 years and older. The capacity to make treatment related decisions was evaluated as most 
challenging with the age limit for these choices being above 11.5 years. Because of lower numbers 
we do not present the evaluations of the parents. 
Factors Influencing Decision-making Process 
With regard to the provision of information the results highlight that for all six aspects of information 
provision (diagnosis, prognosis, treatment options, cancer cause, response to treatment, and clinical 
trial inclusion) parents’ and physicians’ perceptions differed significantly (Table 3). Compared to 
physicians, parents rated the amount of information that was given to them by the physicians as 
being less satisfactory. 
Second, concerning children’s understanding of disease related information, results indicate that 
parents evaluated children’s ability to understand diagnosis and prognosis higher than how it was 
evaluated by the physicians. Parents thus had a more capable image of their children (Table 3). 
Regarding the characteristics of disease, parents’ and physicians’ ratings of the suffering of a child 
as well as the expected treatment duration differed significantly. Parents assessed the disease of their 
child as worse (higher suffering, longer duration) than how physician evaluated the disease. Finally, 
concerning satisfaction with involvement in the decision-making process, parents rated a child’s 
satisfaction with the actual decision-making as higher than the physician (Table 3). 
Parents’ Preferred and Current Role in Decision-making 
Study results present that parents held a less active role than they actually wanted, Z = -3.080, p = 
0.002. Of the parents who reported both their current and preferred role, 64 per cent (47 of 74) 
reported that their current roles matched their preferred role; 8 per cent (6 of 74) reported a more 
active role, and 28 per cent (21 of 74) reported a less active role (Table 3). In order to further 
examine this difference in current and preferred roles, an exploratory GLMM analysis was 
performed addressing the question what determines parents’ less active role. This analysis did not 
reveal any predictors. 
Characteristics of Children Involved in Decision-making 
 Only 44 (out of 137) children were involved in decision-making. They belonged to these age groups: 
3 out of 50 children from 0-4 years, 6 out of 36 children from 5-9 years, 23 out of 38 children from 
10-14 years, and 12 out of 13 from 15-17 years. The findings from the GLMM reveal that a patient’s 
age and gender significantly predicted whether the child was involved or not (Table 4). In particular, 
the older a child the more likely was his or her involvement. Also girls were more likely to be 
involved than boys. To illustrate, an additional year in age resulted in higher odds of being involved 
by a factor of 1.7; for a girl instead of a boy the odds increase by a factor of 3.7. An exploratory 
independent samples t-test (t(76) = 2.079, p = .041, d = .048) revealed that parents evaluated girls’ 
capacity (M = 1.95, SD = 1.58) to make treatment decisions higher than boys’ capacity (M = 2.75, 
SD = 1.43). 
 
Discussion 
By providing findings on children’s actual involvement in decision-making, on parents’ and 
physicians’ evaluations of children’s capacity to understand disease-related information and make 
treatment-related decisions, and on parents’ roles in shared decision-making, this study presents new 
data contributing to the limited literature to date in shared decision-making in pediatric oncology, 
particularly Swiss pediatric oncology setting. The findings suggest appropriate and feasible ways to 
facilitate shared decision-making in pediatric oncology for all stakeholders. The study is unique as it 
highlights the dyad perspective on the same case. 
Results from our dyad perspective first highlights that in comparison to physicians, parents rated the 
amount of information (on diagnosis, prognosis etc.) that they received as less satisfactory. Since 
studies have shown that most parents want to be informed honestly and frequently, also with respect 
to (poor) prognosis, this deficit in communication is likely to reduce parental satisfaction with 
decision-making (Mack and Joffe 2014; Mack et al. 2006; October et al. 2014; Wangmo et al. 
2016b). For example, one study reported that the main reason for conflicts between physicians and 
parents was the latters’ overly optimistic assessment of their child’s prognosis (de Vos et al. 2011). 
In addition, parents perceived the fate of their children (i.e. treatment duration, suffering) as worse 
than how physicians perceived it. They thus felt that their children were suffering more and that the 
treatment seemed to be a long-lasting process. This divergence in the perception of information 
received can be because physicians avoided full disclosure to maintain hope. Although hope is a 
strong emotional motive, it may not produce the desired outcome in light of the value placed by the 
family on proper and adequate information in such situations (Hinds et al. 2001; Jones, Contro, and 
Koch 2014; Mack et al. 2006). On the contrary, full disclosure of prognosis is not only recommended 
 by international guidelines (Association for Children's Palliative Care 2009), but can promote 
parental hope and peace of mind (Mack and Joffe 2014).  Other explanations for this difference are 
information that was not sufficiently tailored to the parents’ need, by ineffective consent documents 
as well as difficulties associated with understanding complex information in a stressful situation with 
limited time (Eder et al. 2007). There is thus a need to assess whether information provided is 
actually understood by the family (White et al. 2007) and mechanism to ensure clear communication 
between the healthcare providers and the family (Ruhe et al. 2015a). 
Second, parents held a more positive view of children’s capacities as they rated the child’s capacity 
to understand diagnosis and prognosis information higher than the physicians. This could be because 
they deemed their children more capable, perceived inclusion as being helpful, or were simply 
hopeful. Parent’s more positive view raises the question whether physicians underestimate children’s 
capacities or parents overestimate their children’s abilities or whether the view of parents and 
physicians depend on factors not related to the child (e.g. the time when information was received, 
educational level of the parent, gender). Exploring the reasons behind parental and professional 
assessment of child’s capacity is a fruitful area of investigation that is lagging presently (Ruhe et al. 
2015a). 
Third, as expected our study findings point that the likelihood of children’s involvement in decision-
making increases with age. While Hinds concluded that children between 10 and 20 years of age are 
capable of participating in end-of-life decisions, in our sample only 69 per cent of this age group 
were involved, even though decisions considered in our study were not of this type and could be seen 
as being less cumbersome (Hinds et al. 2005). The qualitative findings from this project reveal that 
children and adolescents valued being involved in their treatment decisions (Ruhe et al. 2015b; 
Wangmo et al. 2016a). Therefore, stronger involvement of children in light of their increasing age is 
recommendable for two reasons: age is highly correlated with the development of a child and 
involving children is internationally recommended (American Academy of Pediatrics 2000; 
Association for Children's Palliative Care 2009; Craig et al. 2007). Furthermore, guidelines highlight 
that children’s level of understanding is often underestimated and that adolescents are aware of failed 
treatments (National Hospice and Palliative Care Organization 2009; World Health Organization 
1998). Besides guidelines’ recommendations and physicians’ facilitation of children’s involvement 
in decision-making, parents have the responsibility to make their child’s voices heard. However, this 
parental ability can be limited, for example, by their burden of coping with their child’s disease (Kars 
et al. 2015), and exclusion of children from medical discussions because they wish to protect their 
child (Zwaanswijk et al. 2007). Related to inclusion of a pediatric patient, an interesting finding of 
our study is that girls were more likely to be involved even when there was neither age nor prognosis 
 difference between boys and girls. An explanation from our exploratory analysis is that participating 
parents considered girls more capable of making treatment decisions than boys. Future research 
should carefully examine this finding. 
Finally, similar to results from a study carried out in the USA, our study found that only 64 per cent 
of the parents held their preferred, 28 per cent a less active, and 8 per cent a more active role (Mack 
et al. 2011). It should be noted that there was no difference between parents’ and physicians’ 
evaluation of the parents’ preferred role in decision-making. That means that participating physicians 
in our sample perceived the parental preferences correctly but the realization of preferred roles was 
hindered. This is concerning since a study pointed out that holding a less active role was associated 
with lower evaluation of communication quality (Mack et al. 2011). One reason for parents’ less 
active roles could be that physicians were critical of the parental roles, namely parents holding too 
much decisional authority, and therefore restricted parents’ participation (Carnevale et al. 2012). In 
face of their child’s disease parents often want to gather further expert opinions (Eder et al. 2007), 
and it could be that parents did not receive enough time to make a decision in light of time 
constraints in clinical practice (Gravel, Legare, and Graham 2006). It is important to take parental 
preferences into account and to conduct research on decision-making because this can influence 
practice in pediatric oncology (Sung and Regier 2013). Thus barriers that hinder shared decision-
making and individual level factors that affect such process need further evaluation to close this gap 
between perceived and current parental roles. 
Limitations 
The limitations of this study include the different time range during which data was collected in the 
eight participating centers. One center that refused participation, but we do not believe that parents 
and physicians in that center would have provided a significantly different response. Second, 
physicians carried out survey dissemination to the families. We can neither ascertain the number of 
families to whom the study was explained and study materials distributed, nor the number of families 
who refused to participate. The response rate calculated in the methods section is limited to the 
number of surveys completed by the physicians which composed our known denominator. Third, 80 
per cent of the participating parents were mothers. Since mothers are more likely to carry out the 
main responsibility for their child during these situations, it is a legitimate overrepresentation. 
Fourth, from the 151 children, only for 78 the dyad-perspective was captured. Correspondingly, for 
48 per cent of the children only one perspective was available and thus comparative analysis could 
not be performed for all children cases. However, the number of dyad-perspectives is sufficient to 
derive statements about differences between physicians and parents. Finally, as our aim was to gather 
information about children who had cancer, we did not differentiate their disease trajectory. 
 Therefore, this information was not gathered in our survey, and there could be an effect of the point 
along the child’s disease trajectory on the results. Given that participating parent and the physician 
completed their surveys on the same child (dyad-perspective) within a few weeks, it is not very 
likely that the point along the disease trajectory differed significantly within a dyad. 
Conclusion 
Our study provides both valuable insights into the decision-making of physicians and parents, and 
information to improve the decision-making process. It reveals the need from the part of healthcare 
providers to ensure that information provision is clear and correctly understood by the family. They 
should not take for granted that the information they relate to the family is perceived the way it is 
intended. That a girl patient is more likely to be involved in decision-making than a boy patient of 
the same age cautions both physician and parents to evaluate their perception of a child’s capacity so 
that a capable male child is not denied participation. Additionally, our results note that physicians 
fail to ensure the preferred role of the parents. Measures to ensure that parents are enabled to enact 
their preferred roles in decision making will be valuable to ensure good communication and family’s 
satisfaction with health care. Finally, our findings can be applied beyond pediatric oncology to the 
general aim of facilitating the optimal participation of parents and pediatric patients in shared 
decision-making.
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